Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phylos' cytokine microarrays gains US grant:

This article was originally published in Clinica

Executive Summary

Biopharmaceutical firm Phylos has gained a grant from the US National Institute of Allergy and Infectious Disease (NIAID) to develop protein microarrays using the firm's Trinectin binding proteins as capture and detection agents. The multiplex array is a high-throughput product that measures cytokines in small volumes of biological samples. The grant, the second from the NIAID, will fund the project over the next two years, says the Lexington, Massachusetts firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel